HealthEquity reported $3.10M of remaining performance obligations at 31 Jul 2026, down 73% from a year earlier and down 38% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.99.
Net new backlog added in the latest quarter: -$1.90M.
82% of the backlog is due within the next twelve months.
Twelve-month book-to-bill: 0.99, i.e. 0.99 of new orders for every 1 of revenue recognised.
Backlog growth minus revenue growth: -80 points — revenue is catching up with orders.
By backlog size it ranks 535th among US filers the cockpit tracks.
HealthEquity backlog history
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter end
Backlog (RPO)
TTM revenue
Coverage
Customer prepayments
31 Jul 2026
$3.10M
$1.36B
0.0 yrs
n/a
30 Apr 2026
$5.00M
$1.34B
0.0 yrs
n/a
31 Jan 2026
$6.70M
$1.31B
0.0 yrs
n/a
31 Oct 2025
$8.60M
$1.29B
0.0 yrs
n/a
31 Jul 2025
$11.5M
$1.27B
0.0 yrs
n/a
30 Apr 2025
$14.4M
$1.24B
0.0 yrs
n/a
31 Jan 2025
$17.1M
$1.20B
0.0 yrs
n/a
31 Oct 2024
$19.2M
$1.15B
0.0 yrs
n/a
31 Jul 2024
$22.6M
$1.10B
0.0 yrs
n/a
30 Apr 2024
$5.30M
$1.04B
0.0 yrs
n/a
31 Jan 2024
$6.20M
$1,000M
0.0 yrs
n/a
31 Oct 2023
$5.80M
$971M
0.0 yrs
n/a
Questions
What is HealthEquity's backlog?
HealthEquity reported $3.10M of remaining performance obligations at 31 Jul 2026, down 73% from a year earlier and down 38% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 0.99.
About these numbers
Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.